Repositioning a JAKi to Reduce Mortality in Patients with COVID-19

Time: 11:45 am
day: Day One

Details:

  • Rationalizing the use of a JAKi in COVID-19 patients
  • Reviewing the data from a phase 3 COVID-19 trial
  • Exploring other potential novel therapeutic targets for Baricitinib

Speakers: